Whitney Linsenmeyer, PhD, RD, Assistant Professor of Nutrition and Dietetics Reduced Appetite Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, meaning it mimics the effects of GLP-1, a naturally occurring hormone which activates GLP-1 receptors that are found throughout the pancreas, gastrointestinal tract, and brain
PubMed , European Journal of Clinical Pharmacology , vol
GLP-1 Connect was built to give people a place to have those conversations, learn from one another, and feel less alone on their journey." Members of GLP-1 Connect can: Connect with others using or considering GLP-1 therapies Share experiences related to diabetes, obesity, metabolic health, cardiovascular health, and chronic disease management Discuss treatment expectations, side effects, nutrition, exercise, and long-term wellness strategies Learn from peer experiences and community-driven conversations Access educational resources and support from individuals navigating similar health journeys Like all Inspire communities, GLP-1 Connect is free to join and is built around respectful, supportive conversations
GLP-1 medication therapy may be appropriate for men experiencing challenges with weight management or metabolic health
What I saw with compounded semaglutide is that some batches had serious dosing errors